HA

Hugh Alsop

Dimerix Limited | Non-Executive Director
Mr Alsop is an executive with experience in international business development, partnering, drug development and leadership of scientific teams. Hugh is currently CEO of Kinoxis Therapeutics, a private company developing novel therapeutics for substance use disorders and other neurological conditions. Prior to Kinoxis, Hugh was CEO of venture-backed private company Hatchtech, where he was responsible for several drug development programs for the international markets. Hugh is also a non-Executive director of private companies Servatus Ltd, Eflare Corporation Pty Ltd, Avalyn Australia Pty Ltd, AnaptysBio Pty Ltd and Lassen Therapeutics1 Pty Ltd.

Company and Role

Company
Title
Tenure
Since
DXB
DXB
Dimerix Limited
  • Non-Executive Director
7yrs, 7mthMay 2017

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
DXB
DXB
Dimerix Limited
21/10/240N/A300,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
DXB
DXB
Dimerix Limited
21/10/24
Issued
300,000$0.367$110,148Employee Share Ownership Plan
DXB
DXB
Dimerix Limited
30/07/24
Expiry
167,202$0.435$72,732Options expired
DXB
DXB
Dimerix Limited
05/10/21
Issued
167,202$0.270$45,144Director remuneration
DXB
DXB
Dimerix Limited
21/04/21
Expiry
125,000$0.260$32,500Options expired
DXB
DXB
Dimerix Limited
17/11/17
Issued
125,000$0.175$21,875Issue of options.